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Soluble guanylate cyclase (sGC) is the primary receptor
for nitric oxide (NO), which enhances GTP to cGMP con-
version by sGC ~200-fold. The second messenger, cGMP,
further modulates the activity of kinases and ion channels
and ultimately induces smooth muscle relaxation and
vasodilation. In cases of endothelial dysfunction, dimin-
ished NO production and insufficient output of the NO-
sGC-cGMP pathway contribute to cardiovascular diseases,
hepatic and renal failure, and impotence. Compounds
that activate sGC (activators/stimulators) offer a promis-
ing strategy to treat these diseases.
So far, the structural details underlying sGC activation by
NO and/or activators are lacking. The x-ray structures of
independent proteins homologous to sGC independent
domains have been determined, but there is currently no
information on how the different domains assemble and
interact in full-length sGC. Furthermore, despite extensive
studies, the exact mechanism by which NO and/or activa-
tor binding to sGC allosterically activates cGMP produc-
tion, remains elusive.
Our laboratory has initiated structural studies of sGC to
identify the binding site(s) of sGC activators and to deter-
mine the mechanism for sGC activation. Here, we will
present our latest results combining molecular biology,
protein chemistry, x-ray crystallography, and small-angle
x-ray scattering.
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